0001209191-21-018358.txt : 20210305
0001209191-21-018358.hdr.sgml : 20210305
20210305183319
ACCESSION NUMBER: 0001209191-21-018358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210303
FILED AS OF DATE: 20210305
DATE AS OF CHANGE: 20210305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLANK BURKHARD
CENTRAL INDEX KEY: 0001073409
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31938
FILM NUMBER: 21720037
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
BUSINESS PHONE: 914-347-4300
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-03
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001073409
BLANK BURKHARD
420 SAW MILL RIVER ROAD
ARDSLEY
NY
10502
0
1
0
0
CMO and Head of R&D
Common Stock
2021-03-03
4
A
0
11125
0.00
A
18527
D
Award of restricted stock units, each representing a contingent right to one share of common stock which, subject to continued service, vests in installments of 40%, 20%, and 40% at 6 months, 12 months, and 18 months, respectively, after the grant date.
Holdings were adjusted to reflect the issuer's 1-for-6 reverse stock split effected on December 31, 2020.
/s/ Burkhard Blank
2021-03-05